Abstract: The system includes a processor configured for receiving biomedical documents including an identifier of the target and/or of the disease; specifying an offset time the offset time indicating a time interval ahead of the performing of the prediction; specifying a time window ending at the begin of the offset time; extracting a plurality of features selectively from the ones of the received documents published during the time window; providing a classifier having been trained on training features extracted from biomedical training documents published within a training time window ending at the begin of the offset time ahead of a moment the outcome of one or more training studies on training target-disease-pairs was disclosed; executing the classifier, thereby providing the extracted features as input; and outputting a classification result indicating whether the drug directed at the target can be used to treat the disease.

Abstract: Stable powderous formulations containing a fat-soluble active ingredient, e.g., vitamin A, in a matrix of a native lupin protein composition are disclosed.

Abstract: A process for the production of cross-linked beadlets containing one or more active ingredients selected from the group of a fat-soluble vitamin active material, a carotenoid and a polyunsaturated fatty acid is provided. The process comprises treating a dry particulate form at a temperature in the range of from 90° C. to 140° C. for a time period of from 30 seconds to 30 minutes or from 1 minute to 10 minutes or from 3 minutes to 7 minutes.

Abstract: Stable powderous formulations containing a fat-soluble active ingredient, e.g., vitamin A, in a matrix of a native lupin protein composition are disclosed.

Abstract: Suitable powderous formulations containing a fat-soluble active ingredient, e.g., vitamin A, in a matrix of a native lupin protein composition are disclosed.

Abstract: Stable powderous formulations comprising a fat-soluble active ingredient such as a fat-soluble vitamin, and a milk protein such as a caseinate are disclosed. They can be used as additives for feed, food, beverages and cosmetics.

Abstract: The invention provides a process for the production of cross-linked beadlets containing one or more active ingredients selected from the group of a fat-soluble vitamin active material, a carotenoid and a polyunsaturated fatty acid, the process comprising treating a dry particulate form at a temperature in the range of from 90° C. to 140° C. for a time period of from 30 seconds to 30 minutes or from 1 minute to 10 minutes or from 3 minutes to 7 minutes.